Overdose Prevention
We conduct epidemiologic and intervention research on how to improve the safety of opioid prescribing among Kaiser Permanente members and the larger community. We are committed to finding ways to develop, test, and deliver effective strategies to prevent overdoses from pharmaceutical opioids, heroin, fentanyl, and other drugs. Our patient-centered approaches focus on ways individuals can protect themselves and their families from overdose.
Recent Publications
Overdose Prevention Researchers
-
Ingrid A. Binswanger, MD, MPH, MSSenior Clinician Investigator
-
Jason Glanz, PhDSenior Investigator
-
Stanley Xu, PhDHead of Biostatistics, Senior Investigator
-
Anh Nguyen, PhDResearch Post-Doctoral Fellow
Featured Projects
-
+
The Safety and Impact of Expanded Access to Naloxone in Health Systems
Investigators: Ingrid A. Binswanger, MD, MPH, MS and Jason Glanz, PhD and Stanley Xu, PhD
This study examines the impact and safety of expanded access to naloxone, an effective opioid antidote which reverses opioid overdose, for patients prescribed opioids for pain in two large and diverse health systems.
Funder: National Institute on Drug Abuse
Study End Date: 04/30/2021
-
+
Assessing the Safety and Effectiveness of Opioid Tapering in Large Health Systems
Investigators: Ingrid A. Binswanger, MD, MPH, MS and Jason Glanz, PhD
The major goal of this project is to conduct a longitudinal cohort study to determine the effectiveness and safety of opioid tapering in three large health systems in two states.
Funder: National Institute on Drug Abuse
Study End Date: 12/31/2022